CHEMICAL VITILIGO: A LITERATURE REVIEW

Authors

  • Katerina Damevska University Clinic for Dermatology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Igor Peev University Clinic for Plastic and Reconstructive Surgery, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia
  • Ordanche Ribarski Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Republic of North Macedonia

Keywords:

Chemical vitiligo, Chemical leucoderma, Skin hypopigmentation

Abstract

Chemical vitiligo is an underdiagnosed form of skin depigmentation caused by repeated chemical agent exposure, affecting both adults and children. Chemical vitiligo is also called chemical leucoderma, contact vitiligo, and/or occupational vitiligo. Most of the implicated chemical agents are derivates of phenol and catechol, which have melanotoxic effects in individuals with genetic susceptibility. The diagnosis of chemical vitiligo is based on the medical history and patch testing, as histopathology is usually inconclusive and cannot differentiate chemical from idiopathic vitiligo. Patients typically report multiple exposures to specific melanotoxic or depigmenting chemical substances, either in the household or at the workplace, followed by the appearance of diffuse confetti-like and/or pea-sized hypopigmented macules, usually on the face, hands, and feet. The widespread distribution of hypopigmented macules is often the result of sensitization, autotransfer, or heterotransfer of the chemical agent from the primary site of contact. Later, the clinical suspicion of chemical vitiligo can be confirmed with the patch test. Once the diagnosis is established, the patient should be advised to avoid the incriminated chemical agent. In some cases, when spontaneous repigmentation does not occur, additional treatments are recommended, such as ultraviolet B phototherapy, photochemotherapy, and topical immunosuppressants.  

References

Ghosh S. Chemical leukoderma: what's new on etiopathological and clinical aspects? Indian J Dermatol. 2010 Jul-Sep;55(3):255-8. doi: 10.4103/0019-5154.70680

Ghosh S. Chemical Vitiligo: A Subset of Vitiligo. Indian J Dermatol. 2020 Nov-Dec;65(6):443-449. doi: 10.4103/ijd.IJD_291_20

Bonamonte D, Vestita M, Romita P, Filoni A, Foti C, Angelini G. Chemical Leukoderma. Dermatitis. 2016;27(3):90-9. doi:10.1097/DER.0000000000000167

Doolan BJ, Ross G. Systematic review of occupational chemical leukoderma. Int J Dermatol. 2020 Mar;59(3):e50-e52. doi: 10.1111/ijd.14712

Harris JE. Chemical-Induced Vitiligo. Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006

Gozali MV, Zhang JA, Yi F, Zhou BR, Luo D. Chemical leukoderma induced by dimethyl sulfate. An Bras Dermatol. 2016 ;91(5 suppl 1):26-28. doi: 10.1590/abd1806-4841.20164972

Ghosh S, Mukhopadhyay S. Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol. 2009 Jan;160(1):40-7. doi: 10.1111/j.1365-2133.2008.08815.x

D'Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling Pathways in Melanogenesis. Int J Mol Sci. 2016 Jul 15;17(7):1144. doi: 10.3390/ijms17071144

Odedra S, Yoo J. The risk of chemical leucoderma with skin-lightening therapies. Clin Exp Dermatol. 2021 Oct;46(7):1391-1393. doi: 10.1111/ced.14724

Ghosh S, Mukhopadhyay S. Chemical leucoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country. Br J Dermatol. 2009 Jan;160(1):40-7. doi: 10.1111/j.1365-2133.2008.08815.x.

O'Reilly KE, Patel U, Chu J, Patel R, Machler BC. Chemical leukoderma. Dermatol Online J. 2011 Oct 15;17(10):29. PMID: 22031655.

Damevska K et al. (2019) Hypopigmentation from chemical and physical agents. In: Hypopigmentation; Nicolaidou E, Dessinioti C, Katsambas A. (eds), CRC Press, Taylor & Francis Group

Downloads

Published

2025-06-12

Issue

Section

Review Article